BL-8040, a Peptidic CXCR4 Antagonist, Induces Leukemia Cell Death and Specific Leukemia Cell Mobilization in Relapsed/Refractory Acute Myeloid Leukemia Patients in an Ongoing Phase IIa Clinical Trial

This article has no abstract
Epistemonikos ID: d72d49483d22d4115edf00b03ccf66c273940bac
First added on: Feb 19, 2025